Tag: Innovation-Driven Biotech
Firms guide Anthem Biosciences’ USD359m IPO on BSE, NSE
Cyril Amarchand, Trilegal and White & Case advised on Anthem Biosciences’ INR33.95 billion IPO, oversubscribed nearly 64 times
Cyril Amarchand, Trilegal and White & Case advised on Anthem Biosciences’ INR33.95 billion IPO, oversubscribed nearly 64 times
A 1,200-article code, five interlocking books, and one tighter leash on Chinese business. The clock to August 2026 is ticking